Meeting
2016 Genitourinary Cancers Symposium
A 17-gene genomic prostate score (GPS) as a predictor of biochemical (BCR) and clinical recurrence (CR) in men with surgically treated intermediate- and high-risk prostate cancer (PCa).
Authors
Eric A. Klein
Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH
Eric A. Klein , Nan Zhang , Michael Crager , Tara Maddala , Phillip G. Febbo , Shibu Thomas , Michael Gormley , Deborah Sokol Ricci , Sara Moscovita Falzarano , Cristina Magi-Galluzzi , H. Jeffrey Lawrence
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 104)
DOI
10.1200/jco.2016.34.2_suppl.104
Abstract #
104
Poster Bd #
E20
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Genomic validation of three-tiered sub-classification of high-risk prostate cancer.
First Author: Vinayak Muralidhar
Poster
2023 ASCO Breakthrough
Genomic predictors for early recurrence of hepatocellular carcinoma (HCC) after curative resection.
First Author: Lisha Huang
Poster
2023 ASCO Annual Meeting
Minimal residual disease by circulating tumor DNA as a biomarker of recurrence free survival in resected high-risk melanoma patients treated with mRNA-4157/V940, a personalized cancer vaccine, and pembrolizumab.
First Author: Matteo S. Carlino
Poster
2023 ASCO Genitourinary Cancers Symposium
Geographic variation of decipher genomic classifier in patients with early prostate cancer.
First Author: Daniel Keizman